Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 47 of 122)
- Relevance
  Sort by

Saxagliptin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
72 Pages
Global

From

€3500EUR$4,205USD£3,144GBP

Obesity Market (2023 Edition) - Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By Gender, By Region, By Country: Drivers, Trends and Forecast to 2029

 Report
August 2023
270 Pages
Global

From

€2184EUR$2,450USD£1,896GBP

CTLA-4 Inhibitors for Cervical Cancer Market - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Retinal Drugs and Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,205USD£3,144GBP

HPV Associated Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cough Remedy - Global Strategic Business Report

 Report
October 2025
383 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Cough Remedies - Global Strategic Business Report

 Report
October 2025
274 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Lymphoma Therapeutics - Global Strategic Business Report

 Report
October 2025
406 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

B-Cell Lymphoma Treatment - Global Strategic Business Report

 Report
October 2025
392 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Hodgkins Lymphoma Treatment - Global Strategic Business Report

 Report
October 2025
127 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

 Report
December 2023
134 Pages
Global

From

€2207EUR$2,475USD£1,915GBP

€4414EUR$4,950USD£3,830GBP

Mycosis Fungoides Therapeutics - Global Strategic Business Report

 Report
October 2025
182 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics - Global Strategic Business Report

 Report
October 2025
273 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report

 Report
October 2025
192 Pages
Global

From

€5216EUR$5,850USD£4,527GBP

Cervical Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Cancer Vaccines Market - Global Forecast 2025-2032

 Report
October 2025
186 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Pharmaceuticals Global Market Report 2022, By Drug Type, Distribution Channel, Drug Classification

 Report
March 2022
500 Pages
Global

From

€5350EUR$6,000USD£4,643GBP

Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030

 Report
October 2019
231 Pages
Global

From

€4011EUR$4,499USD£3,481GBP

Peptide Vaccine for Tumor Market - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
292 Pages
Global

From

€2229EUR$2,500USD£1,934GBP

2,434 Results (Page 47 of 122)
- 1
- 45
- 46
- 47
- 48
- 49

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.